FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155262085> ?p ?o ?g. }

• W2155262085 endingPage "27" @default.
• W2155262085 startingPage "1744" @default.
• W2155262085 abstract "Chemotherapeutic treatment results in chronic pain in an estimated 30-40 percent of patients. Limited and often ineffective treatments make the need for new therapeutics an urgent one. We compared the effects of prophylactic cannabinoids as a preventative strategy for suppressing development of paclitaxel-induced nociception. The mixed CB1/CB2 agonist WIN55,212-2 was compared with the cannabilactone CB2-selective agonist AM1710, administered subcutaneously (s.c.), via osmotic mini pumps before, during, and after paclitaxel treatment. Pharmacological specificity was assessed using CB1 (AM251) and CB2 (AM630) antagonists. The impact of chronic drug infusion on transcriptional regulation of mRNA markers of astrocytes (GFAP), microglia (CD11b) and cannabinoid receptors (CB1, CB2) was assessed in lumbar spinal cords of paclitaxel and vehicle-treated rats.Both WIN55,212-2 and AM1710 blocked the development of paclitaxel-induced mechanical and cold allodynia; anti-allodynic efficacy persisted for approximately two to three weeks following cessation of drug delivery. WIN55,212-2 (0.1 and 0.5 mg/kg/day s.c.) suppressed the development of both paclitaxel-induced mechanical and cold allodynia. WIN55,212-2-mediated suppression of mechanical hypersensitivity was dominated by CB1 activation whereas suppression of cold allodynia was relatively insensitive to blockade by either CB1 (AM251; 3 mg/kg/day s.c.) or CB2 (AM630; 3 mg/kg/day s.c.) antagonists. AM1710 (0.032 and 3.2 mg/kg /day) suppressed development of mechanical allodynia whereas only the highest dose (3.2 mg/kg/day s.c.) suppressed cold allodynia. Anti-allodynic effects of AM1710 (3.2 mg/kg/day s.c.) were mediated by CB2. Anti-allodynic efficacy of AM1710 outlasted that produced by chronic WIN55,212-2 infusion. mRNA expression levels of the astrocytic marker GFAP was marginally increased by paclitaxel treatment whereas expression of the microglial marker CD11b was unchanged. Both WIN55,212-2 (0.5 mg/kg/day s.c.) and AM1710 (3.2 mg/kg/day s.c.) increased CB1 and CB2 mRNA expression in lumbar spinal cord of paclitaxel-treated rats in a manner blocked by AM630.Cannabinoids block development of paclitaxel-induced neuropathy and protect against neuropathic allodynia following cessation of drug delivery. Chronic treatment with both mixed CB1/CB2 and CB2 selective cannabinoids increased mRNA expression of cannabinoid receptors (CB1, CB2) in a CB2-dependent fashion. Our results support the therapeutic potential of cannabinoids for suppressing chemotherapy-induced neuropathy in humans." @default.
• W2155262085 created "2016-06-24" @default.
• W2155262085 creator A5000540926 @default.
• W2155262085 creator A5010158051 @default.
• W2155262085 creator A5012489562 @default.
• W2155262085 creator A5043286031 @default.
• W2155262085 creator A5043806086 @default.
• W2155262085 creator A5061500959 @default.
• W2155262085 creator A5071641808 @default.
• W2155262085 creator A5082964334 @default.
• W2155262085 date "2014-01-01" @default.
• W2155262085 modified "2023-10-14" @default.
• W2155262085 title "Prophylactic Cannabinoid Administration Blocks the Development of Paclitaxel-Induced Neuropathic Nociception during Analgesic Treatment and following Cessation of Drug Delivery" @default.
• W2155262085 cites W144127422 @default.
• W2155262085 cites W1512522134 @default.
• W2155262085 cites W1542530495 @default.
• W2155262085 cites W1570565174 @default.
• W2155262085 cites W1584829548 @default.
• W2155262085 cites W1971032720 @default.
• W2155262085 cites W1974542461 @default.
• W2155262085 cites W1978946159 @default.
• W2155262085 cites W1981147834 @default.
• W2155262085 cites W1984928289 @default.
• W2155262085 cites W1991677710 @default.
• W2155262085 cites W1997761130 @default.
• W2155262085 cites W1999808927 @default.
• W2155262085 cites W2002804792 @default.
• W2155262085 cites W2008749179 @default.
• W2155262085 cites W2014007136 @default.
• W2155262085 cites W2018655546 @default.
• W2155262085 cites W2020010905 @default.
• W2155262085 cites W2024995064 @default.
• W2155262085 cites W2029775732 @default.
• W2155262085 cites W2038423953 @default.
• W2155262085 cites W2038770419 @default.
• W2155262085 cites W2039519643 @default.
• W2155262085 cites W2047010161 @default.
• W2155262085 cites W2047373793 @default.
• W2155262085 cites W2059680343 @default.
• W2155262085 cites W2070535004 @default.
• W2155262085 cites W2074590245 @default.
• W2155262085 cites W2076898181 @default.
• W2155262085 cites W2078879688 @default.
• W2155262085 cites W2078921285 @default.
• W2155262085 cites W2081406767 @default.
• W2155262085 cites W2083316585 @default.
• W2155262085 cites W2093570206 @default.
• W2155262085 cites W2094267095 @default.
• W2155262085 cites W2097659456 @default.
• W2155262085 cites W2098443650 @default.
• W2155262085 cites W2111443510 @default.
• W2155262085 cites W2119352256 @default.
• W2155262085 cites W2132380973 @default.
• W2155262085 cites W2134557769 @default.
• W2155262085 cites W2140673825 @default.
• W2155262085 cites W2170332110 @default.
• W2155262085 cites W2181898446 @default.
• W2155262085 cites W2184694295 @default.
• W2155262085 doi "https://doi.org/10.1186/1744-8069-10-27" @default.
• W2155262085 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3998744" @default.
• W2155262085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24742127" @default.
• W2155262085 hasPublicationYear "2014" @default.
• W2155262085 type Work @default.
• W2155262085 sameAs 2155262085 @default.
• W2155262085 citedByCount "43" @default.
• W2155262085 countsByYear W21552620852015 @default.
• W2155262085 countsByYear W21552620852016 @default.
• W2155262085 countsByYear W21552620852017 @default.
• W2155262085 countsByYear W21552620852018 @default.
• W2155262085 countsByYear W21552620852019 @default.
• W2155262085 countsByYear W21552620852020 @default.
• W2155262085 countsByYear W21552620852021 @default.
• W2155262085 countsByYear W21552620852022 @default.
• W2155262085 countsByYear W21552620852023 @default.
• W2155262085 crossrefType "journal-article" @default.
• W2155262085 hasAuthorship W2155262085A5000540926 @default.
• W2155262085 hasAuthorship W2155262085A5010158051 @default.
• W2155262085 hasAuthorship W2155262085A5012489562 @default.
• W2155262085 hasAuthorship W2155262085A5043286031 @default.
• W2155262085 hasAuthorship W2155262085A5043806086 @default.
• W2155262085 hasAuthorship W2155262085A5061500959 @default.
• W2155262085 hasAuthorship W2155262085A5071641808 @default.
• W2155262085 hasAuthorship W2155262085A5082964334 @default.
• W2155262085 hasBestOaLocation W21552620851 @default.
• W2155262085 hasConcept C118552586 @default.
• W2155262085 hasConcept C126322002 @default.
• W2155262085 hasConcept C148001335 @default.
• W2155262085 hasConcept C15490471 @default.
• W2155262085 hasConcept C170493617 @default.
• W2155262085 hasConcept C2776158853 @default.
• W2155262085 hasConcept C2777107010 @default.
• W2155262085 hasConcept C2777883359 @default.
• W2155262085 hasConcept C2778938600 @default.
• W2155262085 hasConcept C2779245659 @default.
• W2155262085 hasConcept C2780820201 @default.
• W2155262085 hasConcept C2780871563 @default.
• W2155262085 hasConcept C2781118164 @default.
• W2155262085 hasConcept C42219234 @default.

• next